1. Annual report 2023
  2. Research
  3. GReCMaR

GReCMaR

Research Group in Chronic Respiratory Disease

This research team is made up of professionals from different areas and levels of primary health care who carry out their work and research in various centres in the areas of north Barcelona and Maresme, under the guidance and with the participation of the North Metropolitan Research Support Unit. Some of the group's members form part of Maresme study group investigating Community-Acquired Pneumonia (GEMPAC). The basic objective of GReCMaR is to promote and consolidate knowledge within primary health care of the chronicity of respiratory diseases, knowledge which will lead to improved patient care and the optimum use of available resources. The group's lines are centered on prevention (giving up smoking, tertiary prevention, early detection and screening strategies), Service Evaluation (causes of COPD infradiagnosis and study of the diagnostic value of symptoms, signs and complementary tests) and the comobidity, longitudinality and treatment of patients with respiratory diseases.

Group projects

CLINICAL STUDIES

  • Terapia de ejercicio supervisado en sujetos con arteriopatía periférica sintomática. (PI20/00129). Instituto de Salud Carlos III. 2020-2024. IP: Pere Torán Monserrat,Mª Teresa Alzamora Sas.

  • Perfil neurocognitiu de la síndrome post covid en persones adultes de Catalunya: estudi amb mètodes mixtes en un cas-control niat (nested) en cohorts. Breu: Aliança ProHEpiC-19 Cognitiu. (SLT021/21/000055). Generalitat Catalunya. Departament de Salut. 2022-2024. IP: Pere Torán Monserrat.

  • Estudio fase III, no ciego, de un único brazo, multicéntrico para valorar la seguridad y inmunogenicidad de una vacunación de booster con el candidato de proteína recombinante RBD fusion heterodimer (PHH-1V) contra SARS-CoV-2, en adultos previamente vacunados contra la COVID-19. (HIPPRA-HH-5). HIPRA SCIENTIFIC, S.L.U. 2022. IP: Pere Torán Monserrat.

  • A randomized, double blind, double dummy, parallel group, multicenter clinical trial to evaluate the safety and clinical and microbiologic efficacy of oral fosfomycin calcium in adult women with uUTI. (EfFoCa2021). Laboratorios ERN, S.A. 2022IP: Pere Torán Monserrat.

  • Prospective study to establish the immune status in the elderly after receiving a full course of vaccination. Instituto de Salud Carlos III. 2021 IP: Pere Torán Monserrat.

Group publications

JOURNAL PUBLICATIONS

  • Sánchez MI, García Sierra R, Medrano Jiménez R, Bonachela Mompart D, Maella Rius N, Soria Martín E et al. Use of Infrared Thermometry to Observe Temperature Variation Associated with the Healing Process in Wounds and Ulcers: TIHUAP Cohort Study Protocol. Healthcare. 2023;11(12): PMID:37372868.

  • Sanchez Durán MA, Maiz N, Liutsko L, Bielsa Pascual J, García Sierra R, Zientalska AM et al. Universal screening programme for cytomegalovirus infection in the first trimester of pregnancy: study protocol for an observational multicentre study in the area of Barcelona (CITEMB study). BMJ Open. 2023;13(7): PMID:37474185.

  • Iruela Sánchez M, García Sierra R, Lladó Blanch M, Naveros Almenara F, Seda G, Torán Monserrat P. Tipología de las heridas atendidas en atención primaria: estudio transversal multicéntrico. Med. Fam.-SEMERGEN. 2023;49(5):101964-101964. PMID:37075519.

  • Busquet Duran X, Mateu Carrelero B, Bielsa Pascual J, Milian Adriazola L, Salamero Tura N, Torán Monserrat P. Systemic strengths and needs in palliative home care: Exploring complexity. Rev. Clin. Esp. PMID:38101771.

  • Torán P, Montesinos S, Pachon Camacho A, Diez Fadrique G, Ruiz Rojano I, Arteaga I et al. Risky Alcohol Consumption in the Elderly: Screening and Brief Intervention from Primary Care. The ALANE Study, a Randomized Clinical Trial. Beverages. 2023;9(4):

  • de Homdedeu M, Sanchez Moral L, Violan C, Ràfols N, Ouchi D, Martín B et al. Mycobacterium manresensis induces trained immunity in vitro. iScience. 2023;26(6):106873-106873. PMID:37250788.

  • Violán C, Carrasco Ribelles LA, Collatuzzo G, Ditano G, Abedini M, Janke C et al. Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers-Orchestra Project. Vaccines. 2023;11(8): PMID:37631908.

  • Dimitriadis SI, Castells Sánchez A, Roig Coll F, Dacosta Aguayo R, Lamonja Vicente N, Torán Monserrat P et al. Intrinsic functional brain connectivity changes following aerobic exercise, computerized cognitive training, and their combination in physically inactive healthy late-middle-aged adults: the Projecte Moviment. GeroScience. 2023;46(1):573-596. PMID:37872293.

  • Porru S, Monaco MGL, Spiteri G, Carta A, Caliskan G, Violán C et al. Incidence and Determinants of Symptomatic and Asymptomatic SARS-CoV-2 Breakthrough Infections After Booster Dose in a Large European Multicentric Cohort of Health Workers-ORCHESTRA Project. J. Epidemiol. Global Health. 2023;13(3):577-588. PMID:37480426.

  • Verdaguer M, Vallès Peris N, Busquet Duran X, Moreno Gabriel E, Beroiz P, Marañón AA et al. Implementation of Assisted Dying in Catalonia: Impact on Professionals and Development of Good Practices. Protocol for a Qualitative Study. Int. J. Qual. Method. 2023;22

  • Schroder H, Munoz VC, Rovira MU, Ibanez VV, Dominguez JMM, Blanco GR et al. Determinants of the Consumption of Regular Soda, Sport, and Energy Beverages in Spanish Adolescents. Nutrients. 2021;13(6): PMID:34072460.

  • Chacón C, Arteaga I, Martínez Escudé A, Rojano IR, Lamonja Vicente N, Caballeria L et al. Clinical epidemiology of non-alcoholic fatty liver disease in children and adolescents. The LiverKids: Study protocol. PLoS One. 2023;18(10): PMID:37831682.

  • Roig Coll F, Castells Sánchez A, Monté Rubio G, Dacosta Aguayo R, Lamonja Vicente N, Toran Monserrat P et al. Changes in cardiovascular health and white matter integrity with aerobic exercise, cognitive and combined training in physically inactive healthy late-middle-aged adults: the "Projecte Moviment" randomized controlled trial. Eur. J. Appl. Physiol. 2023;124(3):909-924. PMID:37768344.

  • Llamas Reinero E, Vicente Hernández MM, Cabedo Ferreiro R, Manresa Domínguez JM, García Acosta M, Martínez Bueno C et al. Características de las mujeres migradas atendidas por los Servicios de Salud Reproductiva del Institut Català de la Salut. Rev Esp Salud Publica. 2023;97 PMID:36883555.

  • Montero Pons L, Rodríguez Martín D, Esquinas C, García Sierra R, Manresa Domínguez JM, Reyes Lacalle A et al. Adolescents and Young Adults Evaluating a Website for Affective-Sexual Information and Education: Multicenter Cross-Sectional Study. J. Med. Internet Res. 2023;25 PMID:37883153.

  • Julian MT, Ballesta S, Pera G, de Oca A, Soldevila B, Caballeria L et al. Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study. Front. Endocrinol. 2023;131051958-1051958. PMID:36714592.

PROCEEDING PAPERS

  • Hernández R, Hoyo J, Carol M, Nadal R, Juanola A, Soria A et al. Patients with risk factors for liver diseases associated with hepatic steatosis constitute the target population for liver fibrosis assessment in primary care. J. Hepatol. 2023;78664-665.

  • Carmona Cervelló M, León Gómez BB, Lamonja Vicente N, Dacosta Aguayo R, Roger AA, Reynés AF et al. Identification of the impact in people with persistent covid-19 and cognitive complaints. Gac. Sanit. 2023;37249-249.

Anar a l'inici